Pfizer Inc. said Tuesday it discontinued a late-stage study of its cancer drug Sutent as an initial treatment for colon cancer because the drug is not proving effective enough.

Source: Yahoo! News Search Results for colon cancer
Pfizer discontinues Sutent colon cancer study (AP via Yahoo! Finance)

View original: Pfizer discontinues Sutent colon cancer study (AP via Yahoo! Finance)